Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$53.22 - $123.09 $7.61 Million - $17.6 Million
-143,033 Reduced 97.09%
4,294 $254,000
Q1 2022

May 16, 2022

SELL
$101.89 - $150.09 $15.6 Million - $23 Million
-153,337 Reduced 51.0%
147,327 $17.1 Million
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $22.1 Million - $28.6 Million
-186,663 Reduced 38.3%
300,664 $45.3 Million
Q3 2021

Nov 15, 2021

SELL
$93.51 - $129.4 $46 Million - $63.7 Million
-491,899 Reduced 50.23%
487,327 $58.2 Million
Q2 2021

Aug 16, 2021

BUY
$77.0 - $100.19 $75.4 Million - $98.1 Million
979,226 New
979,226 $95.4 Million
Q1 2020

May 15, 2020

SELL
$47.37 - $90.04 $26.1 Million - $49.6 Million
-550,956 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$53.13 - $71.19 $25 Million - $33.6 Million
-471,301 Reduced 46.1%
550,956 $32.8 Million
Q3 2019

Nov 14, 2019

BUY
$57.11 - $73.3 $58.4 Million - $74.9 Million
1,022,257 New
1,022,257 $60.3 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.11B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.